NCT06372548

Brief Summary

A gamification product was developed to guide children with amblyopia to develop rehabilitation training habits by combining cognitive evaluation theory and occlusion therapy. A randomized controlled trial was conducted to examine the ease of use, acceptability and treatment compliance of the game.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 24, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 18, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

April 30, 2026

Status Verified

April 1, 2024

Enrollment Period

1.3 years

First QC Date

March 24, 2024

Last Update Submit

April 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • 8-Item Morisky Medication Adherence Scale (MMAS-8):

    A patient's adherence to therapy can be evaluated using the eight-question Morisky Medication Adherence Scale-8 (MMAS-8).The total score of the MMAS-8 scale is the sum of the scores of the above 8 questions, and the score range is 0\~8. Higher scores indicate better medication adherence. 8 indicates good adherence; 6\~7 indicates moderate adherence; \<6 indicates poor adherence.

    baseline and study completion (after 8 weeks)

Secondary Outcomes (1)

  • User Experience Questionnaire (UEQ)

    study completion (after 8 weeks)

Study Arms (2)

Find You! Cure My Animal Friends

EXPERIMENTAL

Participants in the experimental group completed the game in this app. The goal of the game is to guide the amblyopic children to develop the habit of rehabilitation training, so that the amblyopic children will keep their interest in completing the exercises according to the time in the game. A story of an animal intern doctor is constructed, and the player will play the role of an animal doctor according to the guidance of the plot, wear the corresponding eye patches and complete the set visual training tasks in the game. The study aims to improve the overall treatment adherence by increasing the attractiveness of the visual training game to children, cultivating long-term training habits, and mitigating the negative effects of amblyopia treatment. The path to achieve this goal consists of the following components: (1) narrative content, (2) interactive forms combined with masking therapy, (3) incentives, and (4) visual design that is consistent with children's preferences.

Device: Find You! Cure My Animal Friends

DuoBao Vision Training System

ACTIVE COMPARATOR

Software Co.'s DuoBao Vision Training System. A number of visual function tests and ophthalmology strabismus amblyopia specialist examinatio. The data is transmitted to the data center and the expert intelligent system to develop a targeted personalized amblyopia training program. Control group participants completed the training components in this app.

Device: DuoBao Vision Training System

Interventions

Introduced cognitive evaluation theory combined with masking therapy to develop a gamified product that guides amblyopic children to develop habits for the purpose of rehabilitation training.

Find You! Cure My Animal Friends

This is a visual training app where participants are required to complete several training tasks.

DuoBao Vision Training System

Eligibility Criteria

Age7 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Diagnosis of amblyopia (including refractive amblyopia, strabismic amblyopia and mixed).
  • The child has no significant IQ deficits and has no difficulty communicating with others.
  • The children's teachers and parents gave their informed consent to participate in the experiment. The informed consent form was signed by the parents and is shown in the Appendix.

You may not qualify if:

  • Severe amblyopia.
  • Suffering from other psychological or physical disorders.
  • Parents did not agree to sign the informed consent form or the child was not willing to participate in this experiment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, 200240, China

Location

MeSH Terms

Conditions

AmblyopiaChild BehaviorTreatment Adherence and Compliance

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVision DisordersSensation DisordersNeurologic ManifestationsEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehaviorHealth Behavior

Study Officials

  • Dian Zhu, Dr

    Shanghai Jiao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 24, 2024

First Posted

April 18, 2024

Study Start

March 1, 2023

Primary Completion

June 1, 2024

Study Completion

August 1, 2024

Last Updated

April 30, 2026

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations